DELFI Diagnostics

📍 Palo Alto, United States🗓 Founded 2019👥 176 employees💰 Last funded Jan 2024
Medical and Diagnostic Laboratories🌐 delfidiagnostics.com
Website LinkedIn
DELFI uses AI, machine learning and whole genome sequencing to sensitively detect unique patterns of DNA fragmentation in the blood of patients with cancer.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2019
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2019–2024 · investors recorded per year
2019220241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in DELFI Diagnostics?
DELFI Diagnostics has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did DELFI Diagnostics last raise funding?
The most recent investment in DELFI Diagnostics recorded on gritt.io was in January 2024.
When was DELFI Diagnostics founded?
DELFI Diagnostics was founded in 2019.
What industry is DELFI Diagnostics in?
DELFI Diagnostics operates in Medical and Diagnostic Laboratories. Find similar Medical and Diagnostic Laboratories investors on gritt.io.
Where is DELFI Diagnostics based?
DELFI Diagnostics is headquartered in Palo Alto, United States.